Research Topics
| Lynn E SullivanSummaryAffiliation: Yale University Country: USA Publications
| Collaborators
|
Detail Information
Publications
A meta-analysis of the efficacy of nonphysician brief interventions for unhealthy alcohol use: implications for the patient-centered medical homeLynn E Sullivan
Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
Am J Addict 20:343-56. 2011..4 (95% CI = .3- 2.4) fewer standard drinks per week compared to control (p = .012). Nonphysician brief interventions are modestly effective at reducing drinking in primary care patients with unhealthy alcohol use...
Hepatitis C and HIV infections: implications for clinical care in injection drug usersLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520 8025, USA
Am J Addict 13:1-20. 2004..Providers caring for patients who are or were IDUs must be aware of the management of these diseases and make efforts to integrate their medical care with the treatment of their substance abuse...
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviorsLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
J Subst Abuse Treat 35:87-92. 2008..We conclude that primary-care-based buprenorphine/naloxone treatment is associated with decreased drug-related HIV risk, but additional efforts may be needed to address sex-related HIV risk when present...
Narrative review: buprenorphine for opioid-dependent patients in office practiceLynn E Sullivan
Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
Ann Intern Med 148:662-70. 2008..The different components of treatment; the role of the physician who provides this treatment; and the logistics of treating this growing, multifaceted patient population are also examined...
The impact of alcohol use on depressive symptoms in human immunodeficiency virus-infected patientsLynn E Sullivan
Yale University School of Medicine, 367 Cedar Street, New Haven, CT 06520, USA
Addiction 103:1461-7. 2008..To examine the impact of alcohol use on depressive symptoms in human immunodeficiency virus (HIV)-infected patients...
The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependenceLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8093, USA
Am J Addict 19:53-8. 2010..35%, p = .001). We conclude that both baseline and in-treatment cocaine use is associated with worse treatment outcomes in patients receiving office-based buprenorphine/naloxone and may benefit from targeted interventions...
The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxoneLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
J Acquir Immune Defic Syndr 56:S54-61. 2011..Cocaine use is common in opioid-dependent HIV-infected patients, but its impact on treatment outcomes in these patients receiving buprenorphine/naloxone is not known...
Training HIV physicians to prescribe buprenorphine for opioid dependenceLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 6520 8025, USA
Subst Abus 27:13-8. 2006..HIV physicians' concerns regarding interactions between buprenorphine and HAART need to be addressed in future training efforts...
Initial strategies for integrating buprenorphine into HIV care settings in the United StatesLynn E Sullivan
Yale University School of Medicine, New Haven, CT 06520 8025, USA
Clin Infect Dis 43:S191-6. 2006....
A trial of integrated buprenorphine/naloxone and HIV clinical careLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, USA
Clin Infect Dis 43:S184-90. 2006..We investigated the feasibility and efficacy of integrating buprenorphine, along with 2 levels of counseling, into HIV clinical care...
Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infectionLynn E Sullivan
Yale University School of Medicine, New Haven, CT 06520 8093, United States
Drug Alcohol Depend 117:158-63. 2011..The impact of alcohol consumption on depressive symptoms over time among patients who do not meet criteria for alcohol abuse or dependence is not known...
The case for routine HIV screening and impact of managed careLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
Am J Manag Care 16:S345-51. 2010..Given the public health impact of HIV infection, federal and private partnerships should be considered to establish routine HIV screening practices...
Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependenceLynn E Sullivan
Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
Clin Infect Dis 41:891-6. 2005..This review addresses the introduction of buprenorphine, in terms of public health, policy, and clinical implications for HIV-infected patients and for HIV care providers...
The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?Lynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, P O Box 208025, New Haven, CT 06520 8025, USA
Drug Alcohol Depend 79:113-6. 2005..Treatment outcomes with buprenorphine in a PCC do not vary based on history of prior methadone treatment...
The prevalence and impact of alcohol problems in major depression: a systematic reviewLynn E Sullivan
Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA
Am J Med 118:330-41. 2005..In addition, the literature focuses almost exclusively on patients with alcohol abuse or dependence in psychiatric inpatient settings, and excludes patients with less severe alcohol problems and primary care outpatient settings...
Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug usersLynn E Sullivan
Yale University School of Medicine, New Haven, CT 06520 8025, USA
Addiction 100:150-8. 2005..To examine the role of expanded access to opioid agonist treatment as a means to decrease international HIV transmission...
Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 yearsDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8025, USA
Am J Addict 17:116-20. 2008..Serum transaminases remained stable from baseline. No serious adverse events related to treatment occurred. We conclude that select opioid-dependent patients exhibit moderate levels of retention in primary care office-based treatment...
Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexoneJeanette M Tetrault
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
Alcohol Clin Exp Res 36:318-24. 2012..We sought to determine the impact of naltrexone on hepatic enzymes and HIV biomarkers in HIV-infected patients...
Patient satisfaction with primary care office-based buprenorphine/naloxone treatmentDeclan T Barry
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519 1187, USA
J Gen Intern Med 22:242-5. 2007..Factors associated with satisfaction among patients receiving primary care-based buprenorphine/naloxone are unknown...
Opioids, chronic pain, and addiction in primary careDeclan T Barry
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
J Pain 11:1442-50. 2010..Addressing these barriers in physician training and in existing office-based programs might benefit both noncancer chronic pain patients and their medical providers...
Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependenceDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn 06520, USA
N Engl J Med 355:365-74. 2006..The optimal level of counseling and frequency of attendance for medication distribution has not been established for the primary care, office-based buprenorphine-naloxone treatment of opioid dependence...
Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patientsBrent A Moore
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
J Gen Intern Med 22:527-30. 2007..Prescription opioid dependence is increasing, but treatment outcomes with office-based buprenorphine/naloxone among these patients have not been described...
Integrating buprenorphine treatment into office-based practice: a qualitative studyDeclan T Barry
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519 1187, USA
J Gen Intern Med 24:218-25. 2009..Despite the availability and demonstrated effectiveness of office-based buprenorphine maintenance treatment (BMT), the systematic examination of physicians' attitudes towards this new medical practice has been largely neglected...
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite studyFrederick L Altice
Yale University School of Medicine, New Haven, CT, USA
J Acquir Immune Defic Syndr 56:S22-32. 2011..Having opioid dependence and HIV infection are associated with poor HIV-related treatment outcomes...
Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlatesWilliam C Becker
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8025, United States
Drug Alcohol Depend 94:38-47. 2008..Non-medical use of prescription opioids carries risks including development of abuse/dependence. Such use may correlate with psychiatric, medical, and substance use characteristics...
A randomized trial of cognitive behavioral therapy in primary care-based buprenorphineDavid A Fiellin
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
Am J Med 126:74.e11-7. 2013..To determine the impact of cognitive behavioral therapy on outcomes in primary care, office-based buprenorphine/naloxone treatment of opioid dependence...
Gender and non-medical use of prescription opioids: results from a national US surveyJeanette M Tetrault
Veterans Affairs Clinical Epidemiology Research Center, West Haven, CT, USA
Addiction 103:258-68. 2008..Gender differences exist regarding alcohol and illicit drug use disorders in the United States. Little is known about the gender-related factors associated with non-medical use of prescription opioids...
Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxoneDavid A Fiellin
Departments of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520 8093, USA
J Acquir Immune Defic Syndr 56:S33-8. 2011..Buprenorphine/naloxone allows the integration of opioid dependence and HIV treatment...
The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection preventionFrederick L Altice
AIDS Program, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06510, USA
Clin Infect Dis 43:S178-83. 2006..Dialogue among practitioners and policy makers in the HIV care and substance abuse communities will facilitate an effective expansion of buprenorphine and ensure that these beneficial outcomes are achieved...
Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxoneEmily A Wang
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA
J Gen Intern Med 25:670-4. 2010..Behaviors associated with opioid dependence often involve criminal activity, which can lead to incarceration. The impact of a history of incarceration on outcomes in primary care office-based buprenorphine/naloxone is not known...
Food insecurity is associated with poor virologic response among HIV-infected patients receiving antiretroviral medicationsEmily A Wang
Department of Internal Medicine, Yale University School of Medicine, Harkness Hall Building A 367 Cedar Street, Suite 410A, New Haven, CT 06510, USA
J Gen Intern Med 26:1012-8. 2011..The objective of this study was to examine the impact of food insecurity on HIV disease outcomes in a large cohort of HIV-infected patients receiving antiretroviral medications...
Counseling and directly observed medication for primary care buprenorphine maintenance: a pilot studyBrent A Moore
Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, 495 Congress Ave, Second Floor, New Haven, CT 06519, USA
J Addict Med 6:205-11. 2012..Counseling and medication adherence can affect opioid agonist treatment outcomes. We investigated the impact of 2 counseling intensities and 2 medication-dispensing methods in patients receiving buprenorphine in primary care...
Human immunodeficiency virus testing practices among buprenorphine-prescribing physiciansE Jennifer Edelman
Robert Wood Johnson Foundation Clinical Scholars Program, Yale School of Public Health, New Haven, CT 06520, USA
J Addict Med 6:159-65. 2012....
Substance use in patients with sexually transmitted infections: results from a national U.S. surveyJeanette M Tetrault
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
Am J Addict 19:504-9. 2010..A diagnosis of an STI should prompt clinicians to screen for substance use, in particular, alcohol abuse/dependence and marijuana use. ..
Update in addiction medicine for the generalistAdam J Gordon
Mental Illness Research, Education, and Clinical Center, University of Pittsburgh, Pittsburgh, PA, USA
J Gen Intern Med 22:1190-4. 2007
Brief report: Methadone treatment of injecting opioid users for prevention of HIV infectionLinda R Gowing
University of Adelaide and Drug and Alcohol Services, South Australia, Australia
J Gen Intern Med 21:193-5. 2006..To assess the effects of oral substitution treatment for opioid-dependent injecting drug users on HIV risk behaviors and infections...
Evaluation of a combined online and in person training in the use of buprenorphineErik W Gunderson
Columbia University College of Physicians and Surgeon and New York State Psychiatric Institute, New York, NY, USA
Subst Abus 27:39-45. 2006..Overall, physicians preferred in person instruction and may benefit from additional experiential training and support after curriculum participation...
